mTOR Signaling and Cancer Progression
PI3K/mTOR/AKT Signaling Pathway
TGF - β Signaling Pathway
MicroRNAs
Abnormal Proliferation
The JAK-STAT Signaling Pathway
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 2, 2025

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
Published on: October 23, 2018
Na Zhao1,2, Qiuhong Xiong1, Ping Li1
1Key Laboratory of Chemical Biology and Molecular Engineering of National Ministry of Education, Institutes of Biomedical Sciences, Shanxi University, Taiyuan, 030006, China.
Genetic variations in TSC1 or TSC2 disrupt the TSC complex, leading to tuberous sclerosis complex (TSC) disease. This study identifies miR-199b-3p as a novel regulator of mTOR signaling in TSC.
09:40Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: